| DEXCOM INC. DL-,001 |
| USA |
| Gesundheit |
| US2521311074 / A0D9T1 |
| DC4 (Frankfurt) / DXCM (NASDAQ) |
| FRA:DC4, ETR:DC4, DC4:GR, NASDAQ:DXCM |
| https://www.dexcom.com/ |
|
Dexcom Inc. is a medical device company specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management and metabolic health in the United States and internationally. Its CGM syste..
>Volltext.. |
| 20598.18 Mio. EUR |
| 20084.27 Mio. EUR |
| 4030.9 Mio. EUR |
| 1006.08 Mio. EUR |
| 723.09 Mio. EUR |
| 1.85 EUR |
| 1201.58 Mio. EUR |
| 793.47 Mio. EUR |
| 1245.67 Mio. EUR |
| 0.93 |
| 1.89% |
| 27.93% |
| - |
| - |
| - |
| DEXCOM |
| 01.04.26 |